Synthesis of 2-acylamino, 2-aroylamino and ethoxycarbonyl imino-1,3,4-thiadiazoles as antitumor agents

Turkish Journal of Chemistry

Volumn 31, Issue 2, 2007, Pages 125-134

  Sancak, Kemal ^a   Ünver, Yasemin ^a   Er, Mustafa ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

1,3,4 Thiadiazole; Acetyl chloride; Antitumor activity; Benzoyl chloride; Ethyl chloro formate

Indexed keywords

EID: 34247519748     PISSN: 13000527     EISSN: 13036130     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. P.C. Unangst, G.P. Shrum, D.T. Dyer and D.J. Schrier, J. Med. Chem. 35, 3691-98 (1992).
2. M.D. Mullican, M.W. Wilson, D.T. Connor, C.R. Kostlan and D.J. Schrier, J. Med. Chem. 36, 1090-99 (1993).
3. D.H. Boschelli, D.T. Conner, D.A. Bornemeir, R.D. Dyer, J.A. Kennedy, P.J. Kuipers, G.C. Okonkwo, D.J. Schrier and C.D. Wright, J. Med. Chem. 36, 1802-10 (1993).
4. D.H. Jones, R. Slack, S. Squires and K.H. Wooldridge, J. Med. Chem. 8, 676-80 (1965).
5. R.W. Sidwell, R.K. Robins and I.W. Hillyard, Pharmacol. Ther. 6, 123-8 (1978).
6. J.K. Sughen and T. Yologe, Pharm. Acta Helv. 58, 64-8 (1978).
7. V.I. Kelarev, R.A. Karakhanov, S.Sh. Gasanvo, G.V. Morozova and K.P. Kuatbekova, J . Org. Chem. USSR 29, 323-9 (1993).
8. Sh.A. Shams El-Dine and A.A.B. Hazza, Pharmazie 29, 761-8 (1974).
9. T. Misato, K. Ko, Y. Honma and E. Taniyama, Jpn Kokai 77 25 028 (1977) [Chem. Abstr. 87, (1977) 14705a].
10. J.H. Reisdorff, W. Brandes, H. Scheinpflug, B. Homeyer and P. Roessler, Ger. Offen. 2 533 604 (1977) [Chem. Abstr. 88, (1978) 137064b].
11. G. Van Reet , J. Heeres and L. Wals, US Patent 4 160 838 (1979) [Chem. Abstr. 91, (1979) 175361z].
12. N.S. Habib, S. Abdel-Hamid and M. El-Hawash, Farmaco 44, 1225-32 (1989).
13. M.R. Stillings, A.P. Welbour and D.S. Walter, J. Med. Chem. 29, 2280-84 (1986).
14. J.M. Kane, M.A. Staeger, C.R. Dalton, F.P. Miller, M.W. Dubley, A.M.L. Ogden, J.H. Kehne, H.J. Ketteler, T.C. McCloskey, Y. Senyah, P.A. Chmielewski and J.A. Miller, J. Med. Chem. 37, 125-32 (1994).
15. C. Ainsworth, N.R. Easton, M. Livezey, D.E. Morrison and W.R. Gibson, J. Am. Pharm. Assoc. 5, 383-9 (1962).
16. C.B. Chapleo, M. Myers, P.L. Myers, J.F. Saville, A.C.B. Smith, M.R. Stillings, I.F. Tulloch, D.S. Walter and A.P. Welbour, J. Med. Chem. 29, 2273-80 (1986).
17. J.M. Kane, M.W. Dubley, S.M. Sorenson and F.P. Miller, J. Med. Chem. 31, 1253-58 (1988).
18. R.D. Porsolt, A. Bertin and M. Jalfre, Pharmacodyn. 229, 327-36 (1977).
19. A. Vamvakides, Ann. Pharm. Fr. 48, 154-59 (1990).
20. F. Fujikawa, I. Yamashita, T. Seno, M. Sasaki, M. Naito and S. Tsukuma, Yakugaku Zasshi 86 (a) (1966) 861-864 [Chem. Abstr. 65, (1966) 20086h].
21. L. Canoira, J. Gonzalo Rodriguez, J.B. Subirats, J.A. Escario, I. Jimenez and A.R. Martinez-Fernandez, Eur. J. Med. Chem. 24, 39-42 (1989).
22. S. Masanori, O. Toshiharu, T. Hiroko and Y. Yoshitoku, Jpn. Kokai, Tokyo Koho JP 01 31 762 [89 31 762] (1989) [Chem. Abstr. 111, (1989) 153624s].
23. C. Krishna and K.C. Joshi, P. Chand. Pharmazie 37, 1-12 (1982).
24. G.T. Seaborg, Science 9, 223 (1984).
25. S.N. Sawhney, A. Gupta and P.K. Sharma, Indian J. Heterocycl. Chem. 1, 8 (1991).
26. J.B. Kramer, D.H. Boschelli and D.T. Connor, J. Heterocycl. Chem. 31, 1439 (1994).
27. B.H. Lee, F.E. Dutton, M.F. Clothier, J.W. Bowman, J.P. Davis, S.S. Johnson, E.M. Thomas, M.R. Zantello, E.W. Zinser, J.C. McGuire, D.P. Thompson and T.G. Geary, Bioorg. Medic. Chem. Lett. 9, 1727 (1999).
28. B.A. Teicher, S.D. Liu, J.T. Liu and S.A. Holden, Herman, Anticancer Res. 13, 1549 (1993).
29. W.R. Chegwidden and I.M. Spencer, Inflammopharmaco 3, 231 (1995).
30. S. Parkkila, H. Rajaniemi, A.K. Parkkila, J. Kivela, A. Waheed, S. Pastorekova, J. Pastorek and W.S. Sly, Proc. Natl. Acad. Sci. USA, 97, 2220 (2000).
31. C.T. Supuran and A. Scozzafava, Eur. J. Med. Chem. 35, 867 (2000).
32. J.J. Oleson, A. Sloboda, W.P. Troy, S.L. Halliday, M.J. Landes, R.B. Angier, J. Semb, K. Cyr and J.H. Williams, J. Am. Chem. Soc. 77, 6713-14 (1955).
33. I.H. Krakoff and G.B. Magill, Proc. Soc. Exp. Biol. Med. Chem. 91, 470-72 (1956).
34. P.J. Elson, L.K. Kvols, S.E. Vogl, D.J. Glover, R.G. Hahn, D.L. Trump, P.P. Carbone and J.D. Davis, T. E. Invest New Drugs 6, 97-103 (1988).
35. R.F. Asbury, A. Kramar and D.G. Haller, Am. J. Clin. Oncol. 10, 380- 82 (1987).
36. R.F. Asbury, J. Wilson, J.A. Blessing, H.J. Buchsbaum and P.J. Disaia, Am. J. Clin. Oncol. 9, 334-36 (1986).
37. R.F. Asbury, J.A. Blessing, W.P. McGuire, P. Hanjani and R. Mortel, Am. J. Clin. Oncol. 13, 39-41 (1990).
38. I.H. Krakoff and M.E. Balis, J. Clin. Invest. 38, 907-915 (1959).
39. I.H. Krakoff, Biochem. Pharmacol. 13, 449-59 (1964).
40. G.Y. Locker, J. Khandeker, S. Krauss, H. Reisel, T. Hoeltgen, J. Wolter, M. Haid, R. Hoffman, R. Blough and C. Johnson, C. Cancer Treat. Rep. 71, 649-50 (1987).
41. R.F. Asbury, J.A. Blessing and D. Moore, Am. J. Clin. Oncol. 19, 400-02 (1996).
42. J.A. Nelson, L.M. Rose and L.L. Bennett, Cancer Res. 37, 182-87 (1977).
43. L. Mishra, M.K. Said, H. Itokawa and K. Takeva, Bioorg. Med. Chem. 3, 1241-45 (1995).
44. R. Ustabaş, U. Çoruh, K. Sancak, M. Er, Y. Ünver and M. Yavuz, Acta Crys. Section E 60, 968-70 (2004).
45. K. Sancak, Acta Crys. Section E 61, 2015-17 (2005).
46. G.D. Gray and E. Wickstrom, Biotechniques, 21, 780-82 (1996).